The NCDR and Clinical Practice Guideline Development

Similar documents
ACTION Registry GWTG Research and Publications Update

The Evolving ACC-NCDR Programs: What you need to know for your practice

Transfer in D2B. Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland. The Problem

Daily practice of ACS management in the Gulf: Data from Gulf COAST

CathPCI Registry Poster Abstract

Timing of Surgery After Percutaneous Coronary Intervention

Sanford Chest Pain Network: Improving Rural STEMI Outcomes

Ischemic Heart Disease Interventional Treatment

Cardiothoracic Department October 9, Deborah Winters, RN BSN Clinical Excellence

Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction

Ischemic Heart Disease Interventional Treatment

REFERRAL HOSPITAL. The Importance of Door In Door Out Time DIDO

10-Year Mortality of Older Acute Myocardial Infarction Patients Treated in U.S. Community Practice

Introduction to Acute Mechanical Circulatory Support

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease

Comparing Effectively: The Role of Registries in Comparative Effectiveness Research

Recommendations for criteria for STEMI systems of care: A focus on pharmacoinvasive strategies

Management of ST-elevation myocardial infarction Update 2009 Late comers: which options?

Acute Coronary Syndrome. Sonny Achtchi, DO

Version 4.4. Institutional Outcomes Report 2014Q3. National Outcomes Report Aggregation Date: Jan 12, :59:59 PM

Pragmatic Trial Design to Study Health Policy Interventions: Lessons Learned from ARTEMIS Tracy Y. Wang, MD, MHS, MSc, FACC, FAHA

Pharmaco-Invasive Approach for STEMI

Controversies in Coronary Revascularization. Atlanta CCU April 15, 2016

The Window for Fibrinolysis. Frans Van de Werf, MD, PhD Leuven, Belgium

Managing Quality of ACS Care in VHA The IDH Guideline Key Points and Metrics

Rationale for Left Ventricular Support During Percutaneous Coronary Intervention

National Cardiovascular Data Registry

Supplementary Online Content

Left Main Intervention: Will it become standard of care?

PCI Guidelines: Essentials for Understanding the Appropriate Use Criteria. J. Jeffrey Marshall, MD, FSCAI

What are the most common clinical scenarios that cause a PCI case to be deemed INAPPROPRIATE by AUC?

Chronic Total Occlusions Rajan Patel, MD FACC FAHA FSCAI

News the. Methods Data collection. The NCDR is a national registry of patients undergoing diagnostic cardiac catheterizations

William D. Salerno, M.D. Director, Coronary Care Unit Hackensack University Medical Center Clinical Associate Professor of Medicine, UMDNJ

What do the guidelines say?

Clinical Research State of the Art A View as a Clinical Trialist,, Registry Researcher, Educator, Physician

Rationale for Prophylactic Support During Percutaneous Coronary Intervention

Intro to Science & Quality. Prepared for Emerging Faculty September 2014 Julia Chang, VP Science & Quality

Left Main Intervention: Where are we in 2015?

2013, American Heart Association

Acute Coronary Syndromes: Different Continents, Different Guidelines?

Quality Improvement in the Cath Lab Today and Tomorrow. Sunil V. Rao MD The Duke Clinical Research Institute Duke University Medical Center

Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017

STEMI Linee guida ESC Maddalena Lettino, Italy

Awealth of research in acute coronary syndrome

The Future of Oral Antiplatelets in PAD and CAD Christopher Paris, MD, FACC, FSCAI

Dual Antiplatelet Therapy Made Practical

Management of STEMI in era of Reperfusion. Eagles Peter Moyer, MD, MPH Medical Director Boston EMS, Fire and Police

Do Clinical Practice Guidelines Improve Outcomes?

Cardiogenic Shock and Initiatives to Reduce Mortality

Dashboard and Outcomes Report with Case Studies

The use of percutaneous coronary intervention

National Efforts to Improve Door-to-Balloon Time

David A. Orsinelli, MD, FACC, FASE Professor, Internal Medicine The Ohio State University Division of Cardiovascular Medicine Columbus, Ohio

Vascular Access Safety Training: The VAST Agenda

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes

Physician Self-referral and Health Care Utilization. Rita F. Redberg, MD, MSc Professor of Medicine UCSF Medical Center

Facilitated Percutaneous Coronary Intervention in Acute Myocardial Infarction. Is it beneficial to patients?

presenters 2010 Sameh Sabet Ain Shams University

Διάρκεια διπλής αντιαιμοπεταλιακής αγωγής. Νικόλαος Γ.Πατσουράκος Καρδιολόγος, Επιμελητής Α ΕΣΥ Τζάνειο Γενικό Νοσοκομείο Πειραιά

Benefit of Performing PCI Based on FFR

Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System

Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study

Preoperative Cardiac Risk Assessment: Approach & Guidelines

Mitigating Operator Risk in Complex Interventional Procedures. Tanveer Rab, MD, FACC Ajay Kirtane, MD, FACC Prashant Kaul, MD, FACC

STEMI update. Vijay Krishnamoorthy M.D. Interventional Cardiology

Supplement. NHLBI and ACC/AHA Criteria for Rating Strength of Evidence

Disclosures. Theodore A. Bass MD, FSCAI. The following relationships exist related to this presentation. None

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form

David E. Kandzari, MD Director, Interventional Cardiology Research Scripps Clinic La Jolla, California

Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials Unit Bern Bern University Hospital, Switzerland

Mark C. Bieniarz, MD Andrew Harrell, MD Peter Berger, MD

CABG vs PCI: What do the Guidelines Say?

Treatment of ST-elevation myocardial infarction in China: Where are we?

Get With The Guidelines: Lessons for National Healthcare Improvement Programs

PCIs on Intermediate Lesions NCDR Cath-PCI Registry

Anticoagulation therapy in acute coronary syndromes according to current guidelines

Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine

The Role of DHMC as an ST Elevation Myocardial Infarction Receiving Center in a Regional STEMI Care Network:

CARDIAC REHABILITATION

3309 Risk-Standardized Survival Rate (RSSR) for In-Hospital Cardiac Arrest (American Heart Association)

AATS STARS Meeting Miami Beach November 17, 2017

CLINICIAN INTERVIEW RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE. An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA

Should All Patients Be Treated with Ace-inh /ARB after STEMI with Preserved LV Function?

Regional STEMI Transfer Systems: the Mayo and NC RACE Experiences

Controversies in Cardiac Pharmacology

Original Article Impact of timing to coronary angiography in acute coronary syndrome on contemporary clinical practice

Professional Society Roles in Drug-Device Cardiac Safety

From the a Duke Clinical Research Institute, Durham, NC, Singapore, Singapore,

Data Requirements. Accreditation for Cardiovascular Excellence Quality in Invasive Cardiovascular Care

National registries for quality improvement and research

Stent For Life, Egypt A Success Story. Hany Ragy MD, FSCAI NHI, Cairo,

Trends in U.S. Cardiovascular Care: 2016 Report from 4 ACC National Cardiovascular Data Registries

Incidence and Treatment for LM In-Stent

Blue Distinction Centers for Cardiac Care 2018 Provider Survey

STEMI AND MULTIVESSEL CORONARY DISEASE

Chronic Total Occlusions. Stephen Cook, MD Medical Director, Cardiac Catheterization Laboratory Oregon Heart & Vascular Institute

Coronary stenting: the appropriate use of FFR

ACCP Cardiology PRN Journal Club

COURAGE to Leave Diseased Arteries Alone

Transcription:

The NCDR and Clinical Practice Guideline Development Gregory J. Dehmer, MD, FACC, FACP, FSCAI Professor of Medicine Texas A&M HSC College of Medicine Director, Cardiology Division Baylor Scott & White Health, Central Texas Guidelines These Days, We Have Many Sources of Information that Provide Structure Around the Practice of Cardiology Where and how does the NCDR fit in? The NCDR and Clinical Practice Guidelines Clinical Studies Adapted from: Antman & Peterson, Circulation 2009:119:1180-1185. 1185. 1

Clinical Practice Guidelines (CPGs) Before the 1980 s physicians relied upon experience and intuition to guide patient care First ever guideline was in 1984 J Am Coll Cardiol 1984; 4:434-42. 42. Clinical Practice Guidelines (CPGs) ACC/AHA partner with other professional organizations to provides guidelines and other documents Rely on evidencebased care/randomized trials If no evidence available, expert opinion Clinical Practice Guidelines Clinical Practice Guidelines (CPG) (State of Science) Exhaustive review of the literature and knowledge base Heavy reliance on RCTs, if any Best practices Should do, should not do Class I = you should do this Class III = don t do this no benefit or harm Class II = conflicting data Maybe OK, sometimes (we re not sure, need more research, debatable, etc...) Level of evidence A: multiple populations studied, multiple RCT, meta-analyses B: limited populations, one RCT C very limited populations, expert consensus opinion 2

Guidelines Don t Just Happen http://assets.cardiosource.com/methodology_manual_for_acc_aha_writing_committees.pd f Are the Guidelines Perfect? JAMA 2009;301:831-41 In the 16 current guidelines: Only 11% of all recommendations were LOE = A 48% LOE C Only 19% of Class I recommendations were LOE = A The Link Between CPGs and the NCDR Science -tells us what we cando; Guidelines tells us what we shoulddo; Then how do we know what we are doing? Are we following the guidelines? Are we improving outcomes for patients? Roe MT, et al. J Am Coll Cardiol 2010 2009:56:254 :56:254-263. 263. 3

Clinical Outcomes? We can only manage what we measure The Link Between CPGs and the NCDR Science -tell us what we cando; Guidelines tell us what we shoulddo; Registries -tell us what we aredoing The clinical yardstick of our performance The Link Between CPGs and the NCDR Science -tells us what we can do; Guidelines tells us what we should do; Registries -tells us what we are actually doing Examined: 131,980 STEMI and NSTEMI patients from ACTION-GWTG Registry 1,708,247 patients from the Cath PCI Registry Roe MT, et al. J Am Coll Cardiol 2010 2009:56:254 :56:254-263. 263. 4

Registries Tell Us What We Are Doing We Are Improving! AMI Performance Composite Trend STEMI trend p value < 0.0001 NSTEMI trend p value < 0.0002 AMI Defect Free Care Trend STEMI trend p value < 0.0001 NSTEMI trend p value < 0.0008 AMI Risk-Adjusted Mortality Trend STEMI trend p value < 0.025 NSTEMI trend p value < 0.026 NCDR Contributions to CPGs NCDR model for in-hospital mortality cited Peterson ED, et al. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coll Cardiol. 2010;55:1923 32. NCDR Helps Change CPG NCDR CathPCI Registry Data: January 2004 March 2006 299,429 patients at 405 facilities with on-site surgery 8,736 patients at 60 facilities without onsite surgery J Am Coll Cardiol 2009;54:16 24. 5

Class IIb Class III Data from 14,821 patients from the ACTION-GWTG Registry Median DIDO time was 68 minutes with only 11% < 30 minutes Analysis of 412,617 PCIs STEMI excluded Grouped by Guideline indication class Circulation 2005;112:2786-91. 6

Relationship Between Procedure Indications and Outcomes of PCI by ACC/AHA Guidelines % 2 1.8 1.6 1.4 1.2 1 0.8 0.6 0.4 0.2 0 All p<0.001 MI CABG Death Class I Class IIa Class IIb Class III Anderson et al. Circulation 2005; 112:2786 The Feedback Cycle Clinical Trials Guidelines Performance Measures AUC Measurement New Gaps Identified Registries Adapted from: Califf RM, et al. J Am Coll Cardiol 2002; 40:1895-901. 901. When the Referee does this in football it means... 7

Remember, without your contributions, there would be no.... 8